Looking to publish in Haemophilia? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowHaemophilia is an international haematology journal dedicated to the worldwide exchange of information regarding the comprehensive care of haemophilia and blood disease. It is the official journal of the World Federation of Hemophilia and the European Association for Haemophilia and Allied Disorders.
Looking to publish in Haemophilia? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Haemophilia accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
Letters To The Editor
Editorials
Commentaries
Recent Publications
Severe Bleeding Disorders Patients Who Developed Excess Weight Gain During the COVID‐19 Pandemic Revert to Their Pre‐Pandemic Weight and BMI Percentiles
Teodora Markovic, Michael Shu, Vanessa Bouskill, Cindy Wakefield, Manuel Carcao, Caroline Malcolmson
An Ex Vivo Pharmacodynamic Study of KN057, a Tissue Factor Pathway Inhibitor Neutralizing Antibody, in Plasma Samples From Patients With Haemophilia or VWD3
Mankai Ju, Feng Xue, Wei Sun, Fang Li, Ting Xu, Renchi Yang
Catastrophic Health Expenditure and Health‐Related Quality of Life Impairment in Severe Haemophilia A: A Patient‐Level Cost‐of‐Illness Study From India
M Joseph John, Mridul Makkar, Himanshu Aggarwal, Damanpreet Singh, Soumya Ohja, Diksha Sarwan, Gaurav Jyani, Shankar Prinja
Optimizing Perioperative Management of Haemophilia B With rFIX‐FP: Pharmacokinetic Validation of the Hemoptidose Tool
Xavier Delavenne, Célia Vollard, Nicolas Drillaud, Sabine Castet, Nicolas Luyck, Emilie Hénin, Julien Denis‐Le Seve, Fabienne Volot, Brigitte Tardy, Stéphanie Désage, Benoît Guillet
Acquired von Willebrand Syndrome in Metabolic Dysfunction–Associated Steatohepatitis With Altered VWF Kinetics and a Type 2‐Like Multimer Pattern
Hiroaki Akiyama, Seiji Kakiuchi, Akimasa Sakamoto, Naru Tomigaki, Shutaro Fujioka, Isamu Harima, Ryotaro Niwa, Ikumi Takagi, Yoko Kozuki, Yoshiharu Miyata, Nobuko Iwata
Frequently asked questions
How long does it take to publish?
Submission to first decision (median): 45 days; submission to acceptance (median): 125 days; acceptance to publication (median): 18 days.
Reformat to Haemophilia using Livewrite PremiumIs a cover letter required?
A covering letter is required, signed by the corresponding author, stating on behalf of all authors that the work has not been published and is not being considered for publication elsewhere. Original and review articles should include a word count in the cover letter.
Reformat to Haemophilia using Livewrite PremiumWhat are the publication costs?
Article publication charges may be covered in full or in part through Wiley Open Access Accounts for eligible authors at participating institutions and funders.
Reformat to Haemophilia using Livewrite Premium